We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
+3.41%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
–
AUM
$1.76B
AUM Growth
-$218M
Cap. Flow
-$265M
Cap. Flow %
-15.02%
Top 10 Hldgs %
22.75%
Holding
203
New
31
Increased
55
Reduced
62
Closed
55

Top Buys

Rank Stock Value
1
RNG icon
RingCentral
RNG
+$36.8M
2
ACHC icon
Acadia Healthcare
ACHC
+$30.7M
3
BILL icon
BILL Holdings
BILL
+$20.8M
4
OMC icon
Omnicom Group
OMC
+$15.9M
5
EQX icon
Equinox Gold
EQX
+$14.9M

Top Sells

Rank Stock Value
1
DNB
Dun & Bradstreet
DNB
+$33.6M
2
SLB icon
SLB Ltd
SLB
+$23.7M
3
MTCH icon
Match Group
MTCH
+$22.9M
4
MUR icon
Murphy Oil
MUR
+$19.4M
5
LYFT icon
Lyft
LYFT
+$18.8M

Sector Composition

Rank Sector Weight
1 Technology 25.6%
2 Consumer Discretionary 17.8%
3 Healthcare 16.38%
4 Industrials 9.22%
5 Materials 9.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TXG icon
126
10x Genomics
TXG
$7.16B
$2.73M 0.16%
+236,064
New +$2.15M
BTG icon
127
B2Gold
BTG
$6.72B
$2.67M 0.15%
738,392
-134,102
-15% -$440K
BKD icon
128
Brookdale Senior Living
BKD
$3.31B
$2.66M 0.15%
382,321
-53,849
-12% -$350K
HURC icon
129
Hurco Companies Inc
HURC
$144M
$2.51M 0.14%
132,995
-13,331
-9% -$201K
UFI icon
130
UNIFI
UFI
$132M
$2.38M 0.13%
455,199
-45,633
-9% -$225K
NEOG icon
131
Neogen
NEOG
$2.47B
$2.34M 0.13%
+490,008
New +$2.81M
OXM icon
132
Oxford Industries
OXM
$552M
$2.26M 0.13%
56,250
-76,497
-58% -$3.85M
QCOM icon
133
Qualcomm
QCOM
$172B
$2.16M 0.12%
+13,557
New +$2M
HAE icon
134
Haemonetics
HAE
$3.95B
$2.08M 0.12%
27,815
-78,915
-74% -$5.22M
MTN icon
135
Vail Resorts
MTN
$5.22B
$2M 0.11%
12,734
-848
-6% -$126K
XPER icon
136
Xperi
XPER
$336M
$1.96M 0.11%
+247,955
New +$1.87M
TBI
137
Trueblue
TBI
$318M
$1.88M 0.11%
290,293
-35,969
-11% -$194K
AVD icon
138
American Vanguard Corp
AVD
$68.7M
$1.87M 0.11%
477,603
-77,466
-14% -$323K
RMAX icon
139
RE/MAX Holdings
RMAX
$242M
$1.82M 0.1%
222,991
+47,588
+27% +$369K
KOP icon
140
Koppers
KOP
$945M
$1.1M 0.06%
34,118
-6,710
-16% -$193K
EAF icon
141
GrafTech
EAF
$206M
$1.08M 0.06%
111,032
-14,157
-11% -$125K
JOUT icon
142
Johnson Outdoors
JOUT
$504M
$886K 0.05%
29,284
-5,333
-15% -$139K
FLGT icon
143
Fulgent Genetics
FLGT
$524M
$619K 0.04%
31,125
-205,047
-87% -$4M
PRPL icon
144
Purple Innovation
PRPL
$42.2M
$492K 0.03%
26,963
-3,435
-11% -$63.3K
MDY icon
145
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27B
$451K 0.03%
+797
New +$428K
LEXX icon
146
Lexaria Bioscience
LEXX
$8.87M
$436K 0.02%
33,431
-3,232
-9% -$55.7K
PETS icon
147
PetMed Express
PETS
$41.9M
$325K 0.02%
97,934
-17,806
-15% -$63.4K
ASHR icon
148
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.59B
$203K 0.01%
+7,388
New +$195K
ABNB icon
149
Airbnb
ABNB
$109B
– –
-118,757
Closed -$14.2M
ADM icon
150
Archer Daniels Midland
ADM
$38.2B
– –
-139,667
Closed -$6.71M
4 5
6
7 8

Similar funds

SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
CAG
Csenge Advisory Group Clearwater, Florida $2.18B AUM 16.73% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.19B AUM
ET
Entropy Technologies New York $2.17B AUM 21.46% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
MIAS
Mason Investment Advisory Services Reston, Virginia $2.17B AUM 28.39% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
IIP
Intermede Investment Partners London, United Kingdom $2.16B AUM 18.47% 1-Year Est. Return

Invenomic Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Invenomic Capital Management held 203 positions worth $1.76B, down 11% from $1.98B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Invenomic Capital Management withdrew a net $265M in Q2 2025, closing 55 positions and reducing 62 holdings. Its most notable exit was Dun & Bradstreet, an estimated $33.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Invenomic Capital Management opened a new position in RingCentral worth $40.5M.

  • Invenomic Capital Management's largest Q2 2025 buy was RingCentral: 1,427,359 shares worth $40.5M.
  • Invenomic Capital Management added most to Acadia Healthcare in Q2 2025, an estimated $30.7M increase.
  • Invenomic Capital Management's biggest Q2 2025 reduction was Match Group, cutting an estimated $22.9M.
  • Invenomic Capital Management fully exited Dun & Bradstreet in Q2 2025, selling an estimated $33.6M.
  • Invenomic Capital Management's ten largest holdings make up 23% of its $1.76B portfolio in Q2 2025.
  • Invenomic Capital Management opened 31 new positions and closed 55 in Q2 2025.
  • Invenomic Capital Management's portfolio value fell 11% quarter-over-quarter to $1.76B.

Based on Invenomic Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.